Symbravo

Symbravo · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 30, 2028

~1.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (82)

Mar 10, 2045method-of-use (U-1719)US 12544383
Dec 29, 2041method-of-use (U-1719)US 12370196
May 28, 2040method-of-use (U-1719)US 12128052
May 28, 2040method-of-use (U-1719)US 12551488
May 28, 2040method-of-use (U-1719)US 12551489
May 18, 2038method-of-use (U-4356)US 12472256
May 18, 2038method-of-use (U-4134)US 12472257
May 18, 2038formulationUS 12472258
Apr 11, 2036method-of-use (U-4133)US 10029010
Apr 11, 2036formulationUS 10058614
Apr 11, 2036formulationUS 10137131
Apr 11, 2036method-of-use (U-1719)US 10195278
Apr 11, 2036method-of-use (U-1719)US 10265324
Apr 11, 2036method-of-use (U-1719)US 10363312
Apr 11, 2036method-of-use (U-4134)US 10369224
Apr 11, 2036method-of-use (U-4135)US 10426839
Apr 11, 2036formulationUS 10463736
Apr 11, 2036method-of-use (U-1719)US 10471014
Apr 11, 2036method-of-use (U-1719)US 10471069
Apr 11, 2036method-of-use (U-1719)US 10512692
Apr 11, 2036method-of-use (U-1719)US 10512693
Apr 11, 2036method-of-use (U-1719)US 10517950
Apr 11, 2036method-of-use (U-1719)US 10532101
Apr 11, 2036method-of-use (U-1719)US 10537642
Apr 11, 2036method-of-use (U-1719)US 10561664
Apr 11, 2036method-of-use (U-1719)US 10583144
Apr 11, 2036method-of-use (U-1719)US 10653777
Apr 11, 2036method-of-use (U-1719)US 10688102
Apr 11, 2036method-of-use (U-1719)US 10688185
Apr 11, 2036method-of-use (U-1719)US 10695429
Apr 11, 2036method-of-use (U-1719)US 10695430
Apr 11, 2036method-of-use (U-4136)US 10702535
Apr 11, 2036method-of-use (U-1719)US 10702602
Apr 11, 2036method-of-use (U-1719)US 10722583
Apr 11, 2036method-of-use (U-1719)US 10729696
Apr 11, 2036method-of-use (U-1719)US 10729697
Apr 11, 2036method-of-use (U-1719)US 10729773
Apr 11, 2036method-of-use (U-1719)US 10758617
Apr 11, 2036method-of-use (U-1719)US 10758618
Apr 11, 2036method-of-use (U-1719)US 10780165
Apr 11, 2036method-of-use (U-1719)US 10780166
Apr 11, 2036method-of-use (U-1719)US 10799588
Apr 11, 2036method-of-use (U-1719)US 10821181
Apr 11, 2036method-of-use (U-1719)US 10821182
Apr 11, 2036method-of-use (U-1719)US 10894053
Apr 11, 2036method-of-use (U-1719)US 10905693
Apr 11, 2036method-of-use (U-1719)US 10918722
Apr 11, 2036method-of-use (U-1719)US 10933136
Apr 11, 2036method-of-use (U-1719)US 10933137
Apr 11, 2036method-of-use (U-1719)US 10940153
Apr 11, 2036method-of-use (U-1719)US 10987358
Apr 11, 2036method-of-use (U-1719)US 11013805
Apr 11, 2036method-of-use (U-1719)US 11013806
Apr 11, 2036method-of-use (U-1719)US 11020483
Apr 11, 2036method-of-use (U-1719)US 11045549
Apr 11, 2036method-of-use (U-1719)US 11135295
Apr 11, 2036method-of-use (U-1719)US 11207328
Apr 11, 2036method-of-use (U-1719)US 11219626
Apr 11, 2036method-of-use (U-1719)US 11285213
Apr 11, 2036method-of-use (U-1719)US 11331323
Apr 11, 2036method-of-use (U-1719)US 11369684
Apr 11, 2036method-of-use (U-1719)US 11426414
Apr 11, 2036method-of-use (U-1719)US 11471464
Apr 11, 2036method-of-use (U-1719)US 11471465
Apr 11, 2036method-of-use (U-1719)US 11504429
Apr 11, 2036method-of-use (U-1719)US 11510927
Apr 11, 2036method-of-use (U-1719)US 11571428
Apr 11, 2036method-of-use (U-1719)US 11602563
Apr 11, 2036method-of-use (U-1719)US 11607456
Apr 11, 2036method-of-use (U-1719)US 11617755
Apr 11, 2036method-of-use (U-1719)US 11617756
Apr 11, 2036method-of-use (U-1719)US 11617791
Apr 11, 2036method-of-use (U-1719)US 11628173
Apr 11, 2036method-of-use (U-1719)US 11712441
Apr 11, 2036method-of-use (U-1719)US 11738085
Apr 11, 2036method-of-use (U-1719)US 11759522
Apr 11, 2036method-of-use (U-1719)US 11801250
Apr 11, 2036method-of-use (U-1719)US 11806354
Apr 11, 2036method-of-use (U-1719)US 11826370
Apr 11, 2036method-of-use (U-1719)US 11865117
Apr 11, 2036method-of-use (U-4133)US 12485176
Apr 11, 2036formulationUS 9821075

FDA exclusivities (1)

Jan 30, 2028NPNP1.6y

(meloxicam + rizatriptan benzoate)

all catalysts(0)

News(0)

Report a data issue

comments(0)

Patent cliff

patents (82)

FDA exclusivities (1)